Erectile Dysfunction (ED) Treatments
Find Erectile Dysfunction (ED) Treatments
Medications for Erectile Dysfunction (ED)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Erectile Dysfunction (ED).
Found 5 Approved Drugs for Erectile Dysfunction (ED)
Sildenafil
Brand Names
Revatio, Viagra, Vybrique
Sildenafil
Brand Names
Revatio, Viagra, Vybrique
Form: Injection, Tablet, Film, Powder, For
Method of administration: Oral, Intravenous
FDA approval date: March 27, 1998
Classification: Phosphodiesterase 5 Inhibitor
Adults REVATIO is indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening. Pediatric Patients (1 to 17 Years Old) REVATIO is indicated in pediatric patients 1 to 17 years old for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) to improve exercise ability and, in pediatric patients too young to perform standardized exercise testing, pulmonary hemodynamics thought to underlie improvements in exercise. Adults REVATIO is a phosphodiesterase-5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening. ( 1 ) Pediatric Patients (1 to 17 years old) REVATIO is indicated in pediatric patients 1 to 17 years old for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) to improve exercise ability and, in pediatric patients too young to perform standard exercise testing, pulmonary hemodynamics thought to underlie improvements in exercise ( 1, 14 )
Alprostadil
Brand Names
Caverject, Edex, Prostin
Alprostadil
Brand Names
Caverject, Edex, Prostin
Form: Injection
Method of administration: Intravenous, Intravascular, Intracavernous
FDA approval date: October 16, 1981
Classification: Prostaglandin Analog
CAVERJECT IMPULSE is a prostaglandin E1 agonist indicated For the treatment of erectile dysfunction.
Tadalafil
Brand Names
Adcirca, ALYQ, Cialis, Opsynvi, Tadliq
Tadalafil
Brand Names
Adcirca, ALYQ, Cialis, Opsynvi, Tadliq
Form: Tablet, Suspension
Method of administration: Oral
FDA approval date: November 26, 2003
Classification: Phosphodiesterase 5 Inhibitor
ADCIRCA is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class II – III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (23%).
Vardenafil
Generic Name
Vardenafil
Vardenafil
Generic Name
Vardenafil
Form: Tablet
Method of administration: Oral
FDA approval date: October 26, 2018
Classification: Phosphodiesterase 5 Inhibitor
Vardenafil hydrochloride tablets are indicated for the treatment of erectile dysfunction. Vardenafil hydrochloride tablets are a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction. ( 1 )
Avanafil
Generic Name
Avanafil
Avanafil
Generic Name
Avanafil
Form: Tablet
Method of administration: Oral
FDA approval date: June 14, 2024
Classification: Phosphodiesterase 5 Inhibitor
Avanafil tablets are a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction in adult males. Avanafil tablet is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction ( 1 )
Showing 1-5 of 5
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances